Biogen confirmed as under Dutch dominance-abuse probe over MS drugs
MLex Summary: The Dutch antitrust authority is investigating Biogen to determine whether the prescription drug manufacturer abused its market power in relation to multiple sclerosis treatment, it confirmed on Friday. The...To view the full article, register now.
Already a subscriber? Click here to view full article